Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2025-P-1576

Request that the FDA remove the Mifepristone REMS Program, including but not limited to the Prescriber Certification, Pharmacy Certification, and Patient Agreement form

Documents

Comments

154

Description

OPEN

Key Dates

Comment Period OpensJun 6, 2025

Documents

Type	Title	Posted	Comments	Status
Other	Interim Response to The Attorney General of Massachusetts, et al.	Nov 25, 2025	--

Comment Statistics

Total Comments

154

Keywords

CDER

Citizen Petition

Attorney General of Massachusetts

Attorney General of California

Attorney General of New Jersey

Attorney General of New York

Request that the FDA remove the

Mifepristone REMS Program, including but not

Data from Regulations.gov